These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4611259)

  • 21. Effects of spironolactone on corneal allograft survival in the rat.
    Otasevic L; Gong N; Ritter T; Mergler S; Pleyer U
    Ophthalmic Res; 2007; 39(6):325-9. PubMed ID: 18046085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of histocompatibility differences on corneal graft rejection using inbred rats as the experimental model.
    Mackintosh HT
    Trans Ophthalmol Soc N Z; 1984; 36():35. PubMed ID: 6382747
    [No Abstract]   [Full Text] [Related]  

  • 23. Induction of corneal graft rejection by passive cell transfer.
    Khodadoust AA; Silverstein AM
    Invest Ophthalmol; 1976 Feb; 15(2):89-95. PubMed ID: 1357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Causes of failures in perforating keratoplasty (author's transl)].
    Gnad HD; Witmer R
    Klin Monbl Augenheilkd; 1974 Jun; 164(6):722-7. PubMed ID: 4609097
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of topical FK506 in a corneal graft rejection model in Lewis rats.
    Hikita N; Lopez JS; Chan CC; Mochizuki M; Nussenblatt RB; de Smet MD
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):901-9. PubMed ID: 9112986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The extent of immunological privilege of orthotopic corneal grafts in the inbred rat.
    Katami M; Madden PW; White DJ; Watson PG; Kamada N
    Transplantation; 1989 Sep; 48(3):371-6. PubMed ID: 2675395
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of cells in human corneal grafts. Growth potential in vitro, cellular morphology, and fate of donor cells.
    Basu PK; Carré F
    Can J Ophthalmol; 1973 Jan; 8(1):1-9. PubMed ID: 4574561
    [No Abstract]   [Full Text] [Related]  

  • 28. A pure class II MHC disparity does not induce rejection of cornea or heart grafts in the rat.
    Katami M; Lim SM; Kamada N; Davies HF; Butcher GW; White DJ; Watson PG; Calne RY
    Transplant Proc; 1990 Oct; 22(5):2200-1. PubMed ID: 2219343
    [No Abstract]   [Full Text] [Related]  

  • 29. Experimental corneal allograft rejection.
    Gebhardt BM; Shi W
    Immunol Res; 2002; 25(1):1-26. PubMed ID: 11868932
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: tissue distribution of donor class I major histocompatibility complex antigen-positive cells in the recipient.
    Goto M; Yamaguchi Y; Hamaguchi H; Hisama N; Miyanari N; Ichiguchi O; Mori K; Shirakusa T; Ogawa M
    Transplant Proc; 1995 Apr; 27(2):1625-7. PubMed ID: 7725428
    [No Abstract]   [Full Text] [Related]  

  • 31. The relative immunogenicity of corneal epithelium, stroma, and endothelium. The role of major histocompatibility complex antigens.
    Treseler PA; Foulks GN; Sanfilippo F
    Transplantation; 1986 Feb; 41(2):229-34. PubMed ID: 3511584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of mismatches for major histocompatibility complex and minor antigens on corneal graft rejection.
    Nicholls SM; Bradley BB; Easty DL
    Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2729-34. PubMed ID: 1894472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of correlation between the induction of donor class I and class II major histocompatibility complex antigens and graft rejection.
    Wood KJ; Hopley A; Dallman MJ; Morris PJ
    Transplantation; 1988 Apr; 45(4):759-67. PubMed ID: 3282359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice.
    Yamada J; Kurimoto I; Streilein JW
    Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Susceptibility of corneal allografts and xenografts to antibody-mediated rejection.
    Holán V; Vítová A; Krulová M; Zajícová A; Neuwirth A; Filipec M; Forrester JV
    Immunol Lett; 2005 Sep; 100(2):211-3. PubMed ID: 15869803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histopathology of rejected orthotopic corneal grafts in the rat.
    Callanan DG; Luckenbach MW; Fischer BJ; Peeler JS; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1989 Mar; 30(3):413-24. PubMed ID: 2647659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolonged cold ischemic times and less donor-recipient histocompatibility accelerate graft vascular disease.
    Czer LS; Wong AV; Soukiasian H; Gallagher S; De Robertis M; Trento A
    Transplant Proc; 2011 Dec; 43(10):3863-8. PubMed ID: 22172861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [On the rejection reaction against corneal grafts and first trails with tissue-typed and HLA-adapted donor material (author's transl)].
    Kok-van Alphen CC; Völker-Dieben HJ
    Klin Monbl Augenheilkd; 1978 Aug; 173(2):208-14. PubMed ID: 359905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Significance of HLA antigens in the fate of graft in keratoplasty for leukomas caused by burns].
    Ignatov RK
    Oftalmol Zh; 1977; 32(3):198-202. PubMed ID: 327367
    [No Abstract]   [Full Text] [Related]  

  • 40. Rejection of murine heterotopic corneal transplants.
    Ray-Keil L; Chandler JW
    Transplantation; 1985 May; 39(5):473-7. PubMed ID: 3887689
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.